Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4142_Библиотеки_им_академика_М_И_Перельмана
.pdf
131
65. Cardiac remodeling and physical training post myocardial infarction /
M.A. Garza, E.A. Wason, J.Q. Zhang // World J Cardiol. – 2015. – Vol. 7, № 2. – P.
52-64.
66. Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological
Mechanisms And Pharmacologic Treatment / P.S. Azevedo, B.F. Polegato, M.F.
Minicucci [et al.] // Arq Bras Cardiol. – 2016. – Vol. 106, № 1. – P. 162-169.
67. Cardiovascular Effects and Benefits of Exercise / M.A. Nystoriak, A.Bhatnagar
// Front Cardiovasc Med. – 2018. –Vol. 5. – P. 135.
68. Cardiovascular Changes Associated with Hypertensive Heart Disease and
Aging / S. Saheera, P. Krishnamurthy // Cell Transplant. – 2020. – Vol. 29. – P.
96368972092030.
69. Cardiovascular remodeling in coronary artery disease and heart failure / G.
Heusch, P. Libby, B. Gersh [et al.] // Lancet. – 2014. – Vol. 383, № 9932. – P. 1933-
1943.
70. Cardiovascular Risks Associated with Gender and Aging / J.L. Rodgers, J.
Jones, S.I. Bolleddu [et al.] // J Cardiovasc Dev Dis. – 2019. –Vol. 6, № 2. – P. 19.
71. Cardiovascular risk of high - versus moderate-intensity aerobic exercise in
coronary heart disease patients / Ø. Rognmo, T. Moholdt, H. Ba kken [et al.] //
Circulation. – 2012. – Vol. 126, № 12. – P. 1436-1440.
72. Cardiovascular Safety of Phosphodiesterase Type 5 Inhibitors After Nearly 2
Decades on the Market / R.A. Kloner, I. Goldstein, M.G. Kirby // Sex Med Rev. – 2018.
– Vol. 6, № 4. – P. 583-594.
73. Cachexia, muscle wasting, and frailty in cardiovascular disease / A. Bielecka-
Dabrowa, N. Ebner, M.R. Dos Santos [et al.] // Eur J Heart Fail. – 2020. - Vol. 22, №
12. – P. 2314-2326.
74. Changes in Arterial Stiffness in Response to Various Types of Exercise
Modalities: A Narrative Review on Physiological and Endothelial Senescence
Perspectives / S. Kresnajati, Y.Y. Lin, T. Mündel [et al.] // Cells. – 2022. – Vol. 11, №
22. – P. 3544.
https://t.me/med1917
132
75. Changes in Membrane Ceramide Pools in Rat Soleus Muscle in Response to
Short-Term Disuse / A.M. Petrov, M.N. Shalagina, V.A. Protopopov [et al.] // Int J Mol
Sci. – 2019. – Vol. 20, № 19. – P. 4860.
76. Charlson Comorbidity Index: A Critical Review of Clinimetric Properties /
M.E. Charlson, D. Carrozzino, J. Guidi [et al.] // PsychotherPsychosom. – 2022. – Vol.
91, № 8. – P. 8-35.
77. Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic
Performance / D.J. Handelsman, A.L. Hirschberg, S. Bermon // Endocr Rev. – 2018. –
Vol. 39, № 5. – P. 803-829.
78. Clinical decisions. Testosterone-replacement therapy / R. Swerdloff, B.D.
Anawalt // N Engl J Med. – 2014. – Vol. 371, № 21. – P. 2032-2034.
79. Clinical Features of Acute Coronary Syndrome in Patients with Coronary Heart
Disease and Its Correlation with Tumour Necrosis Factor in Cardiology / R. Guo,
T. Wu, N. Zheng [et al.] // Comput Math Methods Med. – 2022. – Vol. 2022. – P.
3439768.
80. Clinical presentation of paroxysmal supraventricular tachycardia: evaluation of
usual and unusual symptoms / E. Yetkin, S. Ozturk, B. Cuglan [et al.] // Cardiovasc
Endocrinol Metab. – 2020. - Vol. 9, № 4. – P.153-158.
81. Complexity of TNF-α Signaling in Heart Disease / F. Rolski, P. Błyszczuk // J
Clin Med. – 2020. – Vol. 9, № 10. – P. 3267.
82. Comprehensive cardiac rehabilitation as the keystone in the secondary
prevention of cardiovascular disease / A. Jegier, D. Szalewska, A. Mawlichanów [et al.]
// Kardiol Pol. – 2021. –Vol. 79, № 7-8. – P. 901-916.
83. Coronary artery bypass grafting (CABG) vs. percutaneous coronary
intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? -a
review of the evidences on coronary artery disease / C. Spadaccio, U. Benedetto // Ann
Cardiothorac Surg. – 2018. - Vol. 7, № 4. – P. 506-515.
84. Correlation between the expression of inflammatory cytokines IL-6, TNF-α
and hs-CRP and unfavorable fetal outcomes in patients with pregnancy-induced
https://t.me/med1917
133
hypertension / D. Kong, H. Wang, Y. Liu [et al.] // ExpTher Med. – 2018. – Vol. 16, №
3. – P. 1982-1986.
85. Current challenges in cardiac rehabilitation: strategies to overcome social
factors and attendance barriers / S. Chindhy, P.R. Taub, C.J. Lavie [et al.] // Expert Rev
Cardiovasc Ther. – 2020. – Vol. 18, № 11. – P. 777-789.
86. Cytokines in Inflammatory Disease /S. Kany, J.T. Vollrath, B. Relja // Int J
Mol Sci. - 2019. – Vol. 20, № 23. – P. 6008.
87. Delicce A.V., Makaryus A.N. Physiology, Frank Starling Law. 2022 Feb 10.
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. – PMID:
29262149.
88. Determinants of Physical Activity Performed by Young Adults / J. García-
Fernández, J.R. González-López, Á. Vilches-Arenas [et al.] // Int J Environ Res Public
Health. - 2019. – Vol. 16, № 21. – P. 4061.
89. Development and validation of the coronary heart disease scale under the
system of quality of life instruments for chronic diseases QLICD-CHD: combinations of
classical test theory and Generalizability Theory / C. Wan, H. Li, X. Fan [et al.] //
Health Qual Life Outcomes. – 2014. – Vol. 12. – P. 82.
90. Does admission grip strength predict length of stay in hospitalised older
patients? / A. Kerr, H.E. Syddall, C. Cooper [et al.] // Age and Ageing. – 2006. - Vol.
35, № 1. – P. 82-84.
91. Does contemporary exercise-based cardiac rehabilitation improve quality of
life for people with coronary artery disease? A systematic review and meta-analysis / G.
McGregor, R. Powell, P. Kimani [et al.] // BMJ Open. – 2020. – Vol. 10, № 6. – P.
e036089.
92. Dyslipidemia and cardiovascular disease risk among the MASHAD study
Population / M. Hedayatnia, Z. Asadi, R. Zare-Feyzabadi [et al.] // Lipids Health Dis. –
2020. – Vol. 19, № 1. – P. 42.
93. Early Protective Role of Inflammation in Cardiac Remodeling and Heart
Failure: Focus on TNFα and Resident Macrophages / S. Besse, S. Nadaud, E. Balse [et
al.] // Cells. – 2022. – Vol. 11, № 7. – P. 1249.
https://t.me/med1917
134
94. Endothelial dysfunction as a factor leading to arterial hypertension / D. Drożdż,
M. Drożdż, M.Wójcik // PediatrNephrol. – 2022. doi: 10.1007/s00467-022-05802-z.
95. Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential
Biomarkers and Promising Therapeutical Approaches / D.J. Medina-Leyte, O. Zepeda-
García, M. Domínguez-Pérez [et al.] //Int J Mol Sci. –2021. –Vol. 22, № 8. – P. 3850.
96. Endothelial permeability, LDL deposition, and cardiovascular risk factors-a
review / S. Mundi, M. Massaro, E. Scoditti [et al.] // Cardiovasc Res. – 2018. – Vol.
114, № 1. – P. 35-52.
97. Effect of a 6-week and 12-week cardiac rehabilitation program on heart rate
recovery / A. El Missiri, S.A. Amin, I.R. Tawfik [et al.] //Egypt Heart J. – 2020. –Vol.
72, № 1. – P. 69.
98. Effect of Cardiac Rehabilitation on Left Ventricular Diastolic Function in
Patients with Acute Myocardial Infarction / J.H. Lee, J. Kim, B.J. Sun [et al.] // J Clin
Med. – 2021. –Vol. 10, №10. – P. 2088.
99. Effects of Cardiopulmonary Rehabilitation on the Muscle Function of Children
with Congenital Heart Disease: A Prospective Cohort Study / F.J. Ferrer-Sargues, E.
Peiró-Molina, M.À. Cebrià I Iranzo [et al.] // Int J Environ Res Public Health. – 2021. –
Vol. 18, № 11. – P. 5870.
100. Effectiveness of comprehensive cardiac rehabilitation in coronary artery
disease patients treated according to contemporary evidence based medicine: Update of
the Cardiac Rehabilitation Outcome Study (CROS-II) / A. Salzwedel, K. Jensen, B.
Rauch [et al.] // Eur J PrevCardiol. – 2020. - Vol. 27, № 6. – P. 1756-1774.
101. Effects of Concurrent Training on Body Composition and Gut Microbiota in
Postmenopausal Women with Overweight or Obesity / M. Dupuit, M. Rance, C. Morel
[et al.] // Med Sci Sports Exerc. – 2022. –Vol. 54, № 3. – P. 517-529.
102. Effects of Circuit Weight-Interval Training on Physical Fitness, Cardiac
Autonomic Control, and Quality of Life in Sedentary Workers / S.A. Oliveira-Junior, D.
Boullosa, M.L.M. Mendonça [et al.] // Int J Environ Res Public Health. – 2021. – Vol.
18, № 9. – P. 4606.
https://t.me/med1917
135
103. Effects of Concurrent Strength and Endurance Training on Measures of
Physical Fitness in Healthy Middle-Aged and Older Adults: A Systematic Review with
Meta-Analysis / A. Markov, L. Hauser, H. Chaabene // Sports Med. – 2022. – doi:
10.1007/s40279-022-01764-2.
104. Effects of Dominance and Sprint Interval Exercise on Testosterone and
Cortisol Levels in Strength-, Endurance-, and Non-Training Men / G. Zurek, N. Danek,
A. Żurek [et al.] // Biology (Basel). – 2022. – Vol. 11, № 7. – P. 961.
105. Effects of Exercise after Percutaneous Coronary Intervention on Cardiac
Function and Cardiovascular Adverse Events in Patients with Coronary Heart Disease:
Systematic Review and Meta-Analysis / H. Zhang, R. Chang // J Sports Sci Med. –
2019. –Vol. 18, № 2. – P. 213-222.
106. Effects of Exercise Training on Anabolic and Catabolic Hormones with
Advanced Age: A Systematic Review / H. Zouhal, A. Jayavel, K. Parasuraman [et al.] //
Sports Med. – 2022. – Vol. 52, № 6. – P. 1353-1368.
107. Effects of Exercise Training on the Autonomic Nervous System with a Focus
on Anti-Inflammatory and Antioxidants Effects / M. Daniela, L. Catalina, O. Ilie [et al.]
// Antioxidants (Basel). – 2022. – Vol. 11, № 2. – P. 350.
108. Effects of IL-6 Signaling Pathway Inhibition on Weight and BMI: A
Systematic Review and Meta-Analysis / O. Patsalos, B. Dalton, H. Himmerich // Int J
Mol Sci. – 2020. – Vol. 21, № 17. – P. 6290.
109. Effect of Physical Activity/Exercise on Oxidative Stress and Inflammation in
Muscle and Vascular Aging / M. El Assar, A. Álvarez-Bustos, P. Sosa [et al.] // Int J
Mol Sci. – 2022. – Vol. 23, № 15. – P. 8713.
110. Effect of relative handgrip strength on cardiovascular disease among Korean
adults aged 45 years and older: Results from the Korean Longitudinal Study of Aging
(2006-2016) / S.K. Jang, J.H. Kim, Y. Lee // Arch GerontolGeriatr. – 2020. – Vol. 86. –
P. 103937.
111. Effects of Resistance and Endurance Training Alone or Combined on
Hormonal Adaptations and Cytokines in Healthy Children and Adolescents: A
https://t.me/med1917
136
Systematic Review and Meta-analysis / D. Jansson, A.S. Lindberg, E. Lundberg [et al.]
// Sports Med Open. – 2022. – Vol. 8, № 1. – P. 81.
112. Effects of Walking Speed on Total and Regional Body Fat in Healthy
Postmenopausal Women/ J.M. La New, K.T. Borer // Nutrients. – 2022. – Vol. 14, № 3.
– P. 627.
113. Effectiveness and Safety of Four Aerobic Exercise Intensity Prescription
Techniques in Rehabilitation Training for Patients with Coronary Heart Disease / T.
Chen, H. Zhu, Q. Su // Cardiol Res Pract. – 2022. –Vol. 2022. – P. 1647809.
114. Effectiveness of inspiratory muscle training associated with a cardiac
rehabilitation program on sympathetic activity and functional capacity in patients with
heart failure: a study protocol for a randomized controlled trial / J.C. Leite, D.C.
Brandão, S.C.S. Brandão [et al.] //Trials. – 2020. - Vol. 21, № 11. – P. 519.
115. Elevated levels of interleukin 6 and C-reactive protein associated with
cognitive Impairment in heart failure / P. Athilingam, J. Moynihan, L. Chen [et al.] //
Congest Heart Fail. – 2013. – Vol. 19, № 2. – P. 92-98.
116. Emotional triggers in myocardial infarction: do they matter? / D. Edmondson,
J.D. Newman, W. Whang [et al.] // Eur Heart J. – 2013. - Vol. 34, № 4. – P. 300-306.
117. Erectile dysfunction in the elderly: an old widespread issue with novel
treatment Perspectives / P. Gareri, A. Castagna, D. Francomano [et al.] // Int J
Endocrinol. – 2014. – Vol. 2014. – P. 878670.
118. European Prospective Investigation into Cancer and Nutrition (EPIC): study
populations and data collection / E. Riboli, K.J. Hunt, N. Slimani [et al.] // Public
Health Nutr. – 2002. - Vol. 5, № 6В. – P. 1113-1124.
119. Evolving therapies for myocardial ischemia/reperfusion injury / B. Ibáñez, G.
Heusch, M. Ovize [et al.] // J Am CollCardiol. – 2015. – Vol. 65, № 14. – P. 1454-1471.
120. Exercise-based cardiac rehabilitation for coronary heart disease / G. Dibben, J.
Faulkner, N. Oldridge [et al.] // Cochrane Database Syst Rev. –2021. –Vol. 11, № 11. –
P. CD001800.
https://t.me/med1917
137
121. Exercise-induced immune system response: Anti-inflammatory status on
peripheral and central organs / D.D.L. Scheffer, A. Latini // Biochim Biophys Acta Mol
Basis Dis. - 2020. – Vol. 1866, № 10. – P. 165823.
122. Exercise-induced oxidative stress: Friend or foe? / S.K. Powers, R. Deminice,
M. Ozdemir [et al.] // J Sport Health Sci. – 2020. – Vol. 9, № 5. – P. 415-425.
123. Exercise-Induced Regulation of Redox Status in Cardiovascular Diseases: The
Role of Exercise Training and Detraining / T. Tofas, D. Draganidis, C.K. Deli [et al.] //
Antioxidants (Basel). – 2019. – Vol. 9, № 1. – P. 13.
124. Exercise Intensity in Patients with Cardiovascular Diseases: Systematic
Review with Meta-Analysis / C. Gonçalves, A. Raimundo, A. Abreu [et al.] // Int J
Environ Res Public Health. – 2021. – Vol. 18, № 7. – P. 3574.
125. Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art
Review / M.G. DelBuono, R. Arena, B.A. Borlaug [et al.] // J Am Coll Cardiol. – 2019.
– Vol. 73, № 17. – P. 2209-2225.
126. Exercise intolerance in pulmonary arterial hypertension: insight into central
and peripheral pathophysiological mechanisms / F. Potus, R. Paulin, S. Bonnet [et al.] //
EurRespir Rev. – 2021. – Vol. 30, № 160. – P. 200284.
127. Exercise Metabolism: Fuels for the Fire / M. Hargreaves, L.L. Spriet // Cold
Spring Harb Perspect Med. – 2018. – Vol. 8, № 8. – P. 029744.
128. Exercise for Prevention and Relief of Cardiovascular Disease: Prognoses,
Mechanisms, and Approaches / D. Tian, J.Meng // Oxid Med Cell Longev. - 2019. –
Vol. 2019. – P. 3756750.
129. Exercise tolerance testing in a cardiac rehabilitation setting: an exploratory
study of its safety and practicality for exercise prescription and outcome data collection
/ K. Simms, C. Myers, J. Adams [et al.] // Proc (Bayl Univ Med Cent). – 2007. – Vol.
20, № 4. – P. 344-347.
130. Falls, sarcopenia, and growth in early life: findings from the Hertfordshire
cohort study / A.A. Sayer, H.E. Syddall, H.J. Martin [et al.] // Am J Epidemiol. – 2006.
– Vol. 164, № 7. – P. 665-671.
https://t.me/med1917
138
131. Family aspects, physical fitness, and physical activity associated with mental-
health indicators in adolescents / L. Lema-Gómez, C.M. Arango-Paternina, C. Eusse-
López [et al.] //BMC Public Health. – 2021. –Vol. 21, № 1. – P. 2324.
132. Fitness, Fatness, and Mortality in Men and Women From the UK Biobank:
Prospective Cohort Study / J. Tarp, A. Grøntved, M.A. Sanchez-Lastra [et al.] // J Am
Heart Assoc. – 2021. - Vol. 10, № 6. – P. e019605.
133. Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic
diseases in older adults / J. Angulo, M. El Assar, L. Rodríguez-Mañas // Mol Aspects
Med. – 2016. – Vol. 50. – P. 1-23.
134. Gender in cardiovascular diseases: impact on clinical manifestations,
management, and outcomes / V. Regitz-Zagrosek, S. Oertelt-Prigione, E. Prescott [et
al.] // Eur Heart J. – 2016. –Vol. 37, № 1. – P. 24-34.
135. Grip strength and cardiovascular drug use in older people: findings from the
Hertfordshire Cohort Study / T.A. Ashfield, H.E. Syddall, H.J. Martin [et al.] // Age
Ageing. – 2010. – Vol. 39, № 1. – P. 185-191
136. Grip strength predicts cause-specific mortality in middle-aged and elderly
persons / H. Sasaki, F. Kasagi, M. Yamada [et al.] // Am J Med. – 2007. - Vol. 120, №
4. – P. 337-342.
137. Global Epidemiology of Ischemic Heart Disease: Results from the Global
Burden of Disease Study / M.A. Khan, M.J. Hashim, H. Mustafa [et al.] //Cureus. –Vol.
12, № 7. – P. 9349.
138. Hackney, A.C. Hypogonadism in Exercising Males: Dysfunction or Adaptive-
Regulatory Adjustment? / A.C.Hackney // Front Endocrinol (Lausanne). – 2020. – Vol.
11. – P. 11.
139. Heat, Hydration and the Human Brain, Heart and Skeletal Muscles / S.J.
Trangmar, J. González-Alonso // Sports Med. – 2019. –Vol. 49, № 1. – P. 69-85.
140. Heart failure after myocardial nfarction: incidence and predictors / D. Jenča, V.
Melenovský, J. Stehlik [et al.] // ESC Heart Fail. – 2021. –Vol. 8, № 1. – P. 222-237.
141. Heart failure classification in clinical practice: time to redefine? / K. Hu, G.
Ertl, S. Frantz [et al.] // Chin Med J (Engl). –2022. – Vol. 135, № 9. – P. 1039-1040.
https://t.me/med1917
139
142. Heart Plasticity in Response to Pressure - and Volume-Overload: A Review of
Findings in Compensated and Decompensated Phenotypes / F.G. Pitoulis, C.M.
Terracciano // FrontPhysiol. – 2020. – Vol. 11. – P. 92.
143. Heart rate recovery and blood pressure response during exercise testing in
patients with microvascular angina / B.J. Kim, E.A. Jo, S.I. Im [et al.] // ClinHypertens.
– 2019. –Vol. 25. – P. 4.
144. Home-based telerehabilitation is not inferior to a centre-based program in
patients with chronic heart failure: a randomised trial / R. Hwang, J. Bruning, N.R.
Morris [et al.] // J Physiother. - 2017. – Vol. 63, № 2. – P. 101-107.
145. Impact of exercise on the immune system and outcomes in hematologic
malignancies / A. Sitlinger, D.M. Brander, D.B.Bartlett // BloodAdv. – 2020. – Vol. 4,
№ 8. – P. 1801-1811.
146. Impact of Physical Activity and Exercise on the Epigenome in Skeletal Muscle
and Effects on Systemic Metabolism / J. Plaza-Diaz, D.Izquierdo, Á.Torres-Martos [et
al.] //Biomedicines. – 2022. –Vol. 10, № 1. – P. 126.
147. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and
frailty / L. Ferrucci, E.Fabbri // Nat Rev Cardiol. – 2018. – Vol. 15, № 9. – P. 505-522.
148. Inflammation: Roles in Skeletal Muscle Atrophy / Y. Ji, M. Li, M. Chang [et
al.] //Antioxidants (Basel). – 2022. –Vol. 11, № 9. – P. 1686.
149. Inflammatio and Skeletal Muscle Wasting During Cachexia / J.M.
Webster,L.J.A.P. Kempen, R.S. Hardy [et al.] // FrontPhysiol. - 2020. - Vol. 11. – P.
597675.
150. Inflammation: A key process in skin tumorigenesis / M. Neagu, C. Constantin,
C. Caruntu [et al.] // OncolLett. – 2019. – Vol. 17, № 5. – P. 4068-4084.
151. Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and
Gut Microbiota in the Development of Muscle Failure / O.M. Nardone, R. de Sire, V.
Petito [et al.] // Front Immunol. – 2021. – Vol. 12. – P. 694217.
152. Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart
Failure / A. Hanna, N.G. Frangogiannis // Cardiovasc Drugs Ther. – 2020. –Vol. 34, №
6. – P. 849-863.
https://t.me/med1917
140
153. Inflammatory cytokines in the pathogenesis of cardiovascular disease and
cancer / M.N. Amin, S.A. Siddiqui, M. Ibrahim [et al.] // SAGE Open Med. – 2020. –
Vol. 8. – P. 2050312120965752.
154. Inflammatory responses and inflammation-associated diseases in organs / L.
Chen, H. Deng, H. Cui [et al.] // Oncotarget. – 2017. – Vol. 9, № 6. – P. 7204-7218.
155. In-hospital psychological intervention in cardiac rehabilitation following acute
coronary syndrome: Brief is better than nothing / A. Abreu // Rev Port Cardiol (Engl
Ed). – 2019. –Vol. 38, № 5. – P. 369-372.
156. Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases / J.H. Su,
M.Y. Luo, N.Liang [et al.] // Front Pharmacol. – 2021. –Vol. 12. – P. 745061.
157. Interleukin 6-independent metabolic reprogramming as a driver of cancer-
related Fatigue / A.J. Grossberg, E.G. Vichaya, P.S. Gross [et al.] // Brain Behav
Immun. – 2020. –Vol. 8. – P. 230-241.
158. Interleukin-6 level is a powerful predictor of long-term cardiovascular
mortality in patients with acute coronary syndrome / G.M. Gager, B. Biesinger, F. Hofer
[et al.] // VasculPharmacol. – 2020. – Vol. 135. – P. 106806.
159. International Exercise Recommendations in Older Adults (ICFSR): Expert
Consensus Guidelines / M. Izquierdo, R.A. Merchant, J.E. Morley [et al.] // J Nutr
Health Aging. - 2021. –Vol. 25, № 7. – P. 824-853.
160. Interconnection between Cardiac Cachexia and Heart Failure-Protective Role
of Cardiac Obesity / M.E. Soto, I. Pérez-Torres, M.E. Rubio-Ruiz [et al.] // Cells. –
2022. – Vol. 11, № 6. – P. 1039.
161. IL-1β and TNF-α Modulation of Proliferated and Committed Myoblasts: IL-6
and COX-2-Derived Prostaglandins as Key Actors in the Mechanisms Involved / A.M.
Alvarez, C. DeOcesano-Pereira, C. Teixeira [et al.] // Cells. – 2020. –Vol. 9, № 9. – P.
2005.
162. IL-6 and TNFα Drive Extensive Proliferation of Human Tregs Without
Compromising Their Lineage Stability or Function / N. Skartsis, Y. Peng, L.M.R.
Ferreira [et al.] // Front Immunol. – 2021. – Vol. 12. – P. 783282.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана